Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-29 @ 7:52 AM
Study NCT ID:
NCT05098028
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2021-10-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease
Sponsor:
Bausch Health Americas, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-04
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-18
First Submit QC Date:
None
Study First Post Date:
2021-10-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-23
Results First Submit QC Date:
None
Results First Post Date:
2024-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-23
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL